Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global AI In Drug Repurposing Market, by Component
1.4.2 Global AI In Drug Repurposing Market, by Technology
1.4.3 Global AI In Drug Repurposing Market, by End Use
1.4.4 Global AI In Drug Repurposing Market, by Application
1.4.5 Global AI In Drug Repurposing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – AI In Drug Repurposing Market
Chapter 5. State of Competition - AI In Drug Repurposing Market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. Global AI In Drug Repurposing Market by Component
10.1 Global Software & Platform Market by Region
10.2 Global Services Market by Region
Chapter 11. Global AI In Drug Repurposing Market by Technology
11.1 Global Machine Learning/Deep Learning Market by Region
11.2 Global Natural Language Processing (NLP) Market by Region
11.3 Global Knowledge Graphs & Network-Based AI Market by Region
11.4 Global Generative AI & Large Language Models (LLMs) Market by Region
11.5 Global Computer Vision Market by Region
Chapter 12. Global AI In Drug Repurposing Market by End Use
12.1 Global Pharmaceutical & BioTechnology Companies Market by Region
12.2 Global Contract Research Organizations (CROs) Market by Region
12.3 Global Academic & Research Institutes Market by Region
12.4 Global Other End Use Market by Region
Chapter 13. Global AI In Drug Repurposing Market by Application
13.1 Global Oncology Market by Region
13.2 Global Neurology Market by Region
13.3 Global Infectious Diseases Market by Region
13.4 Global Rare & Orphan Diseases Market by Region
13.5 Global Cardiology Market by Region
13.6 Global Other Application Market by Region
Chapter 14. Global AI In Drug Repurposing Market by Region
14.1 North America AI In Drug Repurposing Market
14.2 Key Factors Impacting the Market
14.2.1 Market Drivers
14.2.2 Market Restraints
14.2.3 Market Opportunities
14.2.4 Market Challenges
14.2.5 Market Trends – North America AI In Drug Repurposing Market
14.2.6 State of Competition - North American AI in Drug Repurposing Market
14.2.7 North America AI In Drug Repurposing Market by Component
14.2.7.1 North America Software & Platform Market by Country
14.2.7.2 North America Services Market by Country
14.2.8 North America AI In Drug Repurposing Market by Technology
14.2.8.1 North America Machine Learning/Deep Learning Market by Region
14.2.8.2 North America Natural Language Processing (NLP) Market by Region
14.2.8.3 North America Knowledge Graphs & Network-Based AI Market by Region
14.2.8.4 North America Generative AI & Large Language Models (LLMs) Market by Region
14.2.8.5 North America Computer Vision Market by Region
14.2.9 North America AI In Drug Repurposing Market by End Use
14.2.9.1 North America Pharmaceutical & BioTechnology Companies Market by Country
14.2.9.2 North America Contract Research Organizations (CROs) Market by Country
14.2.9.3 North America Academic & Research Institutes Market by Country
14.2.9.4 North America Other End Use Market by Country
14.2.10 North America AI In Drug Repurposing Market by Application
14.2.10.1 North America Oncology Market by Country
14.2.10.2 North America Neurology Market by Country
14.2.10.3 North America Infectious Diseases Market by Country
14.2.10.4 North America Rare & Orphan Diseases Market by Country
14.2.10.5 North America Cardiology Market by Country
14.2.10.6 North America Other Application Market by Country
14.2.11 North America AI In Drug Repurposing Market by Country
14.2.11.1 US AI In Drug Repurposing Market
14.2.11.1.1 US AI In Drug Repurposing Market by Component
14.2.11.1.2 US AI In Drug Repurposing Market by Technology
14.2.11.1.3 US AI In Drug Repurposing Market by End Use
14.2.11.1.4 US AI In Drug Repurposing Market by Application
14.2.11.2 Canada AI In Drug Repurposing Market
14.2.11.2.1 Canada AI In Drug Repurposing Market by Component
14.2.11.2.2 Canada AI In Drug Repurposing Market by Technology
14.2.11.2.3 Canada AI In Drug Repurposing Market by End Use
14.2.11.2.4 Canada AI In Drug Repurposing Market by Application
14.2.11.3 Mexico AI In Drug Repurposing Market
14.2.11.3.1 Mexico AI In Drug Repurposing Market by Component
14.2.11.3.2 Mexico AI In Drug Repurposing Market by Technology
14.2.11.3.3 Mexico AI In Drug Repurposing Market by End Use
14.2.11.3.4 Mexico AI In Drug Repurposing Market by Application
14.2.11.4 Rest of North America AI In Drug Repurposing Market
14.2.11.4.1 Rest of North America AI In Drug Repurposing Market by Component
14.2.11.4.2 Rest of North America AI In Drug Repurposing Market by Technology
14.2.11.4.3 Rest of North America AI In Drug Repurposing Market by End Use
14.2.11.4.4 Rest of North America AI In Drug Repurposing Market by Application
14.3 Europe AI In Drug Repurposing Market
14.4 Key Factors Impacting the Market
14.4.1 Market Drivers
14.4.2 Market Restraints
14.4.3 Market Opportunities
14.4.4 Market Challenges
14.4.5 Market Trends – Europe AI In Drug Repurposing Market
14.4.6 State of Competition - Europe AI in Drug Repurposing market
14.4.7 Europe AI In Drug Repurposing Market by Component
14.4.7.1 Europe Software & Platform Market by Country
14.4.7.2 Europe Services Market by Country
14.4.8 Europe AI In Drug Repurposing Market by Technology
14.4.8.1 Europe Machine Learning/Deep Learning Market by Country
14.4.8.2 Europe Natural Language Processing (NLP) Market by Country
14.4.8.3 Europe Knowledge Graphs & Network-Based AI Market by Country
14.4.8.4 Europe Generative AI & Large Language Models (LLMs) Market by Country
14.4.8.5 Europe Computer Vision Market by Country
14.4.9 Europe AI In Drug Repurposing Market by End Use
14.4.9.1 Europe Pharmaceutical & BioTechnology Companies Market by Country
14.4.9.2 Europe Contract Research Organizations (CROs) Market by Country
14.4.9.3 Europe Academic & Research Institutes Market by Country
14.4.9.4 Europe Other End Use Market by Country
14.4.10 Europe AI In Drug Repurposing Market by Application
14.4.10.1 Europe Oncology Market by Country
14.4.10.2 Europe Neurology Market by Country
14.4.10.3 Europe Infectious Diseases Market by Country
14.4.10.4 Europe Rare & Orphan Diseases Market by Country
14.4.10.5 Europe Cardiology Market by Country
14.4.10.6 Europe Other Application Market by Country
14.4.11 Europe AI In Drug Repurposing Market by Country
14.4.11.1 Germany AI In Drug Repurposing Market
14.4.11.1.1 Germany AI In Drug Repurposing Market by Component
14.4.11.1.2 Germany AI In Drug Repurposing Market by Technology
14.4.11.1.3 Germany AI In Drug Repurposing Market by End Use
14.4.11.1.4 Germany AI In Drug Repurposing Market by Application
14.4.11.2 UK AI In Drug Repurposing Market
14.4.11.2.1 UK AI In Drug Repurposing Market by Component
14.4.11.2.2 UK AI In Drug Repurposing Market by Technology
14.4.11.2.3 UK AI In Drug Repurposing Market by End Use
14.4.11.2.4 UK AI In Drug Repurposing Market by Application
14.4.11.3 France AI In Drug Repurposing Market
14.4.11.3.1 France AI In Drug Repurposing Market by Component
14.4.11.3.2 France AI In Drug Repurposing Market by Technology
14.4.11.3.3 France AI In Drug Repurposing Market by End Use
14.4.11.3.4 France AI In Drug Repurposing Market by Application
14.4.11.4 Russia AI In Drug Repurposing Market
14.4.11.4.1 Russia AI In Drug Repurposing Market by Component
14.4.11.4.2 Russia AI In Drug Repurposing Market by Technology
14.4.11.4.3 Russia AI In Drug Repurposing Market by End Use
14.4.11.4.4 Russia AI In Drug Repurposing Market by Application
14.4.11.5 Spain AI In Drug Repurposing Market
14.4.11.5.1 Spain AI In Drug Repurposing Market by Component
14.4.11.5.2 Spain AI In Drug Repurposing Market by Technology
14.4.11.5.3 Spain AI In Drug Repurposing Market by End Use
14.4.11.5.4 Spain AI In Drug Repurposing Market by Application
14.4.11.6 Italy AI In Drug Repurposing Market
14.4.11.6.1 Italy AI In Drug Repurposing Market by Component
14.4.11.6.2 Italy AI In Drug Repurposing Market by Technology
14.4.11.6.3 Italy AI In Drug Repurposing Market by End Use
14.4.11.6.4 Italy AI In Drug Repurposing Market by Application
14.4.11.7 Rest of Europe AI In Drug Repurposing Market
14.4.11.7.1 Rest of Europe AI In Drug Repurposing Market by Component
14.4.11.7.2 Rest of Europe AI In Drug Repurposing Market by Technology
14.4.11.7.3 Rest of Europe AI In Drug Repurposing Market by End Use
14.4.11.7.4 Rest of Europe AI In Drug Repurposing Market by Application
14.5 Asia Pacific AI In Drug Repurposing Market
14.6 Key Factors Impacting the Market
14.6.1 Market Drivers
14.6.2 Market Restraints
14.6.3 Market Opportunities
14.6.4 Market Challenges
14.6.5 Market Trends – Asia Pacific AI In Drug Repurposing Market
14.6.6 State of Competition – Asia Pacific AI In Drug Repurposing Market
14.6.7 Asia Pacific AI In Drug Repurposing Market by Component
14.6.7.1 Asia Pacific Software & Platform Market by Country
14.6.7.2 Asia Pacific Services Market by Country
14.6.8 Asia Pacific AI In Drug Repurposing Market by Technology
14.6.8.1 Asia Pacific Machine Learning/Deep Learning Market by Country
14.6.8.2 Asia Pacific Natural Language Processing (NLP) Market by Country
14.6.8.3 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country
14.6.8.4 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country
14.6.8.5 Asia Pacific Computer Vision Market by Country
14.6.9 Asia Pacific AI In Drug Repurposing Market by End Use
14.6.9.1 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country
14.6.9.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
14.6.9.3 Asia Pacific Academic & Research Institutes Market by Country
14.6.9.4 Asia Pacific Other End Use Market by Country
14.6.10 Asia Pacific AI In Drug Repurposing Market by Application
14.6.10.1 Asia Pacific Oncology Market by Country
14.6.10.2 Asia Pacific Neurology Market by Country
14.6.10.3 Asia Pacific Infectious Diseases Market by Country
14.6.10.4 Asia Pacific Rare & Orphan Diseases Market by Country
14.6.10.5 Asia Pacific Cardiology Market by Country
14.6.10.6 Asia Pacific Other Application Market by Country
14.6.11 Asia Pacific AI In Drug Repurposing Market by Country
14.6.11.1 China AI In Drug Repurposing Market
14.6.11.1.1 China AI In Drug Repurposing Market by Component
14.6.11.1.2 China AI In Drug Repurposing Market by Technology
14.6.11.1.3 China AI In Drug Repurposing Market by End Use
14.6.11.1.4 China AI In Drug Repurposing Market by Application
14.6.11.2 Japan AI In Drug Repurposing Market
14.6.11.2.1 Japan AI In Drug Repurposing Market by Component
14.6.11.2.2 Japan AI In Drug Repurposing Market by Technology
14.6.11.2.3 Japan AI In Drug Repurposing Market by End Use
14.6.11.2.4 Japan AI In Drug Repurposing Market by Application
14.6.11.3 India AI In Drug Repurposing Market
14.6.11.3.1 India AI In Drug Repurposing Market by Component
14.6.11.3.2 India AI In Drug Repurposing Market by Technology
14.6.11.3.3 India AI In Drug Repurposing Market by End Use
14.6.11.3.4 India AI In Drug Repurposing Market by Application
14.6.11.4 South Korea AI In Drug Repurposing Market
14.6.11.4.1 South Korea AI In Drug Repurposing Market by Component
14.6.11.4.2 South Korea AI In Drug Repurposing Market by Technology
14.6.11.4.3 South Korea AI In Drug Repurposing Market by End Use
14.6.11.4.4 South Korea AI In Drug Repurposing Market by Application
14.6.11.5 Singapore AI In Drug Repurposing Market
14.6.11.5.1 Singapore AI In Drug Repurposing Market by Component
14.6.11.5.2 Singapore AI In Drug Repurposing Market by Technology
14.6.11.5.3 Singapore AI In Drug Repurposing Market by End Use
14.6.11.5.4 Singapore AI In Drug Repurposing Market by Application
14.6.11.6 Malaysia AI In Drug Repurposing Market
14.6.11.6.1 Malaysia AI In Drug Repurposing Market by Component
14.6.11.6.2 Malaysia AI In Drug Repurposing Market by Technology
14.6.11.6.3 Malaysia AI In Drug Repurposing Market by End Use
14.6.11.6.4 Malaysia AI In Drug Repurposing Market by Application
14.6.11.7 Rest of Asia Pacific AI In Drug Repurposing Market
14.6.11.7.1 Rest of Asia Pacific AI In Drug Repurposing Market by Component
14.6.11.7.2 Rest of Asia Pacific AI In Drug Repurposing Market by Technology
14.6.11.7.3 Rest of Asia Pacific AI In Drug Repurposing Market by End Use
14.6.11.7.4 Rest of Asia Pacific AI In Drug Repurposing Market by Application
14.7 LAMEA AI In Drug Repurposing Market
14.8 Key Factors Impacting the Market
14.8.1 Market Drivers
14.8.2 Market Restraints
14.8.3 Market Opportunities
14.8.4 Market Challenges
14.8.5 Market Trends – LAMEA AI In Drug Repurposing Market
14.8.6 State of Competition - LAMEA AI in Drug Repurposing market
14.8.7 LAMEA AI In Drug Repurposing Market by Component
14.8.7.1 LAMEA Software & Platform Market by Country
14.8.7.2 LAMEA Services Market by Country
14.8.8 LAMEA AI In Drug Repurposing Market by Technology
14.8.8.1 LAMEA Machine Learning/Deep Learning Market by Country
14.8.8.2 LAMEA Natural Language Processing (NLP) Market by Country
14.8.8.3 LAMEA Knowledge Graphs & Network-Based AI Market by Country
14.8.8.4 LAMEA Generative AI & Large Language Models (LLMs) Market by Country
14.8.8.5 LAMEA Computer Vision Market by Country
14.8.9 LAMEA AI In Drug Repurposing Market by End Use
14.8.9.1 LAMEA Pharmaceutical & BioTechnology Companies Market by Country
14.8.9.2 LAMEA Contract Research Organizations (CROs) Market by Country
14.8.9.3 LAMEA Academic & Research Institutes Market by Country
14.8.9.4 LAMEA Other End Use Market by Country
14.8.10 LAMEA AI In Drug Repurposing Market by Application
14.8.10.1 LAMEA Oncology Market by Country
14.8.10.2 LAMEA Neurology Market by Country
14.8.10.3 LAMEA Infectious Diseases Market by Country
14.8.10.4 LAMEA Rare & Orphan Diseases Market by Country
14.8.10.5 LAMEA Cardiology Market by Country
14.8.10.6 LAMEA Other Application Market by Country
14.8.11 LAMEA AI In Drug Repurposing Market by Country
14.8.11.1 Brazil AI In Drug Repurposing Market
14.8.11.1.1 Brazil AI In Drug Repurposing Market by Component
14.8.11.1.2 Brazil AI In Drug Repurposing Market by Technology
14.8.11.1.3 Brazil AI In Drug Repurposing Market by End Use
14.8.11.1.4 Brazil AI In Drug Repurposing Market by Application
14.8.11.2 Argentina AI In Drug Repurposing Market
14.8.11.2.1 Argentina AI In Drug Repurposing Market by Component
14.8.11.2.2 Argentina AI In Drug Repurposing Market by Technology
14.8.11.2.3 Argentina AI In Drug Repurposing Market by End Use
14.8.11.2.4 Argentina AI In Drug Repurposing Market by Application
14.8.11.3 UAE AI In Drug Repurposing Market
14.8.11.3.1 UAE AI In Drug Repurposing Market by Component
14.8.11.3.2 UAE AI In Drug Repurposing Market by Technology
14.8.11.3.3 UAE AI In Drug Repurposing Market by End Use
14.8.11.3.4 UAE AI In Drug Repurposing Market by Application
14.8.11.4 Saudi Arabia AI In Drug Repurposing Market
14.8.11.4.1 Saudi Arabia AI In Drug Repurposing Market by Component
14.8.11.4.2 Saudi Arabia AI In Drug Repurposing Market by Technology
14.8.11.4.3 Saudi Arabia AI In Drug Repurposing Market by End Use
14.8.11.4.4 Saudi Arabia AI In Drug Repurposing Market by Application
14.8.11.5 South Africa AI In Drug Repurposing Market
14.8.11.5.1 South Africa AI In Drug Repurposing Market by Component
14.8.11.5.2 South Africa AI In Drug Repurposing Market by Technology
14.8.11.5.3 South Africa AI In Drug Repurposing Market by End Use
14.8.11.5.4 South Africa AI In Drug Repurposing Market by Application
14.8.11.6 Nigeria AI In Drug Repurposing Market
14.8.11.6.1 Nigeria AI In Drug Repurposing Market by Component
14.8.11.6.2 Nigeria AI In Drug Repurposing Market by Technology
14.8.11.6.3 Nigeria AI In Drug Repurposing Market by End Use
14.8.11.6.4 Nigeria AI In Drug Repurposing Market by Application
14.8.11.7 Rest of LAMEA AI In Drug Repurposing Market
14.8.11.7.1 Rest of LAMEA AI In Drug Repurposing Market by Component
14.8.11.7.2 Rest of LAMEA AI In Drug Repurposing Market by Technology
14.8.11.7.3 Rest of LAMEA AI In Drug Repurposing Market by End Use
14.8.11.7.4 Rest of LAMEA AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
Chapter 16. Winning Imperatives of AI In Drug Repurposing Market
Unique Offerings 